Targeting HER-2 in Gastric Cancer &Ndash; Incorporation of Trastuzumab Into the Treatment of Operable Disease

Gastrointestinal Cancer: Targets and Therapy
doi 10.2147/gictt.s18495
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Changes in 2-Fluoro-2-Deoxy-D-Glucose Incorporation, Hexokinase Activity and Lactate Production by Breast Cancer Cells Responding to Treatment With the Anti-Her-2 Antibody Trastuzumab

Nuclear Medicine and Biology
Cancer ResearchNuclear MedicineRadiologyMolecular MedicineImaging
2011English

Pcn75 - Budget Impact Model of Subcutaneous Trastuzumab Compared With Intravenous Trastuzumab on the Treatment of Her-2 Positive Breast Cancer in the Brazilian Private Healthcare System

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Intrathecal Trastuzumab: Immunotherapy Improves the Prognosis of Leptomeningeal Metastases in HER-2+ Breast Cancer Patient

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Gastric Cancer and Trastuzumab: First Biologic Therapy in Gastric Cancer

Therapeutic Advances in Medical Oncology
Oncology
2013English

Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

New England Journal of Medicine
Medicine
2005English

The Expression and Clinical Significance of PDCD4 and Her-2 in Human Gastric Cancer

European Journal of Inflammation
2019English

HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2004English

Targeting Metastatic Colorectal Cancer &Ndash; Present and Emerging Treatment Options

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2014English

The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer

Scientific Reports
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy